Entry - #620236 - CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 29, WITH POLYGLUCOSAN BODIES; CMH29 - OMIM
 
# 620236

CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 29, WITH POLYGLUCOSAN BODIES; CMH29


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
3q27.1 Cardiomyopathy, familial hypertrophic, 29, with polyglucosan bodies 620236 AR 3 KLHL24 611295
Clinical Synopsis
 
Phenotypic Series
 

INHERITANCE
- Autosomal recessive
CARDIOVASCULAR
Heart
- Syncope, recurrent
- Dyspnea on exertion
- Palpitations
- Increased septal wall thickness
- Increased posterior wall thickness
- Asymmetric septal hypertrophy (in some patients)
- Left ventricular outflow obstruction (in some patients)
- Heart failure
- Lethal arrhythmias
- Cardiomyocyte hypertrophy
- Interstitial fibrosis
- Intermyofibrillar accumulation of glycogen
- Polyglucosan bodies within cardiomyocytes
- Irregularly arranged intermediate filaments
MUSCLE, SOFT TISSUES
- Focal subsarcolemmal accumulation of glycogen
- Intermyofibrillar accumulation of glycogen
- Accumulation of desmin-staining intermediate filaments
- 'Cogwheel-like' appearance of muscle fibers
- No muscular atrophy
- No muscular weakness
- Normal nerve conduction studies
MISCELLANEOUS
- Onset in second to third decade of life
- Patients exhibit no skin abnormalities
- Risk of sudden death
MOLECULAR BASIS
- Caused by mutation in the kelch-like-24 gene (KLHL24, 611295.0001)
Cardiomyopathy, familial hypertrophic - PS192600 - 37 Entries
Location Phenotype Inheritance Phenotype
mapping key
Phenotype
MIM number
Gene/Locus Gene/Locus
MIM number
1p31.1 Cardiomyopathy, hypertrophic, 20 AD 3 613876 NEXN 613121
1q32.1 Cardiomyopathy, hypertrophic, 2 AD 3 115195 TNNT2 191045
1q43 Cardiomyopathy, hypertrophic, 23, with or without LVNC AD 3 612158 ACTN2 102573
1q43 Cardiomyopathy, dilated, 1AA, with or without LVNC AD 3 612158 ACTN2 102573
2q31.2 Cardiomyopathy, familial hypertrophic, 9 AD 3 613765 TTN 188840
3p25.3 Cardiomyopathy, familial hypertrophic AD, DD 3 192600 CAV3 601253
3p21.31 Cardiomyopathy, hypertrophic, 8 AD, AR 3 608751 MYL3 160790
3p21.1 Cardiomyopathy, hypertrophic, 13 AD 3 613243 TNNC1 191040
3q27.1 Cardiomyopathy, familial hypertrophic, 29, with polyglucosan bodies AR 3 620236 KLHL24 611295
4p12 ?Cardiomyopathy, familial hypertrophic, 30, atrial AR 3 620734 CORIN 605236
4q26 Cardiomyopathy, hypertrophic, 16 AD 3 613838 MYOZ2 605602
6q22.31 Cardiomyopathy, hypertrophic, 18 AD 3 613874 PLN 172405
7p12.1-q21 Cardiomyopathy, hypertrophic, 21 AD 2 614676 CMH21 614676
7q32.1 Cardiomyopathy, familial restrictive 5 AD 3 617047 FLNC 102565
7q32.1 Arrhythmogenic right ventricular dysplasia, familial AD 3 617047 FLNC 102565
7q32.1 Cardiomyopathy, familial hypertrophic, 26 AD 3 617047 FLNC 102565
7q36.1 Cardiomyopathy, hypertrophic 6 AD 3 600858 PRKAG2 602743
10q21.3 Cardiomyopathy, dilated, 1KK AD 3 615248 MYPN 608517
10q21.3 Cardiomyopathy, familial restrictive, 4 AD 3 615248 MYPN 608517
10q21.3 Cardiomyopathy, hypertrophic, 22 AD 3 615248 MYPN 608517
10q22.2 Cardiomyopathy, hypertrophic, 15 AD 3 613255 VCL 193065
10q23.2 Left ventricular noncompaction 3 AD 3 601493 LDB3 605906
10q23.2 Cardiomyopathy, dilated, 1C, with or without LVNC AD 3 601493 LDB3 605906
10q23.2 Cardiomyopathy, hypertrophic, 24 AD 3 601493 LDB3 605906
11p15.1 Cardiomyopathy, hypertrophic, 12 AD 3 612124 CSRP3 600824
11p11.2 Cardiomyopathy, hypertrophic, 4 AD, AR 3 115197 MYBPC3 600958
12q24.11 Cardiomyopathy, hypertrophic, 10 AD 3 608758 MYL2 160781
14q11.2 Cardiomyopathy, hypertrophic, 14 AD 3 613251 MYH6 160710
14q11.2 Cardiomyopathy, hypertrophic, 1 AD, DD 3 192600 MYH7 160760
15q14 Cardiomyopathy, hypertrophic, 11 AD 3 612098 ACTC1 102540
15q22.2 Cardiomyopathy, hypertrophic, 3 AD 3 115196 TPM1 191010
15q25.3 Cardiomyopathy, familial hypertrophic 27 AR 3 618052 ALPK3 617608
17q12 Cardiomyopathy, hypertrophic, 25 AD 3 607487 TCAP 604488
18q12.2 Cardiomyopathy, familial hypertrophic, 28 AD 3 619402 FHOD3 609691
19q13.42 Cardiomyopathy, hypertrophic, 7 AD 3 613690 TNNI3 191044
20q11.21 Cardiomyopathy, hypertrophic, 1, digenic AD, DD 3 192600 MYLK2 606566
20q13.12 Cardiomyopathy, hypertrophic, 17 AD 3 613873 JPH2 605267

TEXT

A number sign (#) is used with this entry because of evidence that hypertrophic cardiomyopathy-29 (CMH29) is caused by homozygous mutation in the KLHL24 gene (611295) on chromosome 3q27.


Description

Hypertrophic cardiomyopathy-29 (CMH29) is characterized by recurrent syncope, dyspnea on exertion, and palpitations. The clinical phenotype is associated with a poor prognosis due to lethal arrhythmias and cardiac failure. Cardiac muscle biopsies show intermyofibrillar accumulation of glycogen and polyglucosan bodies within cardiomyocytes, and skeletal muscle accumulation of glycogen has also been observed (Hedberg-Oldfors et al., 2019).

For a general phenotypic description and discussion of genetic heterogeneity of hypertrophic cardiomyopathy, see CMH1 (192600).


Clinical Features

Hedberg-Oldfors et al. (2019) reported 2 unrelated consanguineous families, of Iraqi (family A) and Iranian (family B) origin, segregating autosomal recessive hypertrophic cardiomyopathy (CMH) and mutation in the KLHL24 gene. Of 11 affected young adults in the 2 families, 3 died suddenly and 1 underwent cardiac transplantation due to heart failure. Onset of symptoms was in the second or third decade of life, and the initial symptoms included palpitations, syncope, shortness of breath, and dyspnea on exertion. Echocardiographic findings were reported for 8 patients and showed increased septal and posterior wall thickness, with asymmetric septal hypertrophy in 3 patients. Most had a small left ventricular cavity with reduced left ventricular end-diastolic volumes, and left ventricular outflow obstruction was documented in 3 patients. Cardiac biopsies from an affected sister and brother in family A showed cardiomyocyte hypertrophy, accumulation of glycogen, and scattered cardiomyocytes with polyglucosan bodies. Electron microscopy showed intermyofibrillar accumulation of glycogen, tubular structures, and irregularly arranged intermediate filaments. Skeletal muscle biopsies from patients in both families showed focal subsarcolemmal and intermyofibrillar accumulation of glycogen, as well as intermediate filaments with desmin (DES; 125660) immunostaining, together causing a jagged appearance at the edges of both type 1 and type 2 muscle fibers that the authors designated as 'cogwheel-like.' No signs of muscular atrophy or weakness were found in the patients, and nerve conduction studies were normal. No skin abnormalities were found.


Inheritance

The transmission pattern of CMH29 in the families reported by Hedberg-Oldfors et al. (2019) was consistent with autosomal recessive inheritance.


Mapping

In a large multigenerational Iranian family (family B) segregating autosomal recessive CMH, Hedberg-Oldfors et al. (2019) performed linkage analysis and identified an approximately 3.4-Mb region of homozygosity on chromosome 3 with an estimated lod score of 3.6. The interval was defined by rs9877496 and rs73175592.


Molecular Genetics

By exome sequencing in 2 unrelated families segregating autosomal recessive hypertrophic cardiomyopathy, Hedberg-Oldfors et al. (2019) identified homozygosity for mutations in the KLHL24 gene: in family A, of Iraqi origin, an affected brother and sister were homozygous for a nonsense mutation (E350X; 611295.0005); and in family B, of Iranian origin, 4 sibs and an affected cousin with CMH mapping to chromosome 3 were homozygous for a missense mutation (R306H; 611295.0006). The unaffected parents in both pedigrees were heterozygous for the respective mutations, neither of which was found in the Greater Middle Eastern Variome database. Western blot analysis of cardiac tissue from the sibs in family A showed marked upregulation of desmin.


Animal Model

Hedberg-Oldfors et al. (2019) knocked down the cardiac-specific zebrafish homolog of KLHL24, klhl24a, and observed defects in heart function at 48 hours postfertilization (hpf). The defects initially manifested as pericardial edema, alterations in heart rate, and reduced blood circulation; ventricular failure and blocked blood circulation were observed at 72 hpf. Site-specific mutagenesis corresponding to the human mutations E350X and R306H (see MOLECULAR GENETICS) gave rise to heart defects in more than 70% of embryos, and the mutant mRNA could not rescue the knockdown of endogenous klhl24a.


REFERENCES

  1. Hedberg-Oldfors, C., Abramsson, A., Osborn, D. P. S., Danielsson, O., Fazlinezhad, A., Nilipour, Y., Hubbert, L., Nennesmo, I., Visuttijai, K., Bharj, J., Petropoulou, E., Shoreim, A., and 12 others. Cardiomyopathy with lethal arrhythmias associated with inactivation of KLHL24. Hum. Molec. Genet. 28: 1919-1929, 2019. [PubMed: 30715372, images, related citations] [Full Text]


Creation Date:
Marla J. F. O'Neill : 02/01/2023
Edit History:
alopez : 02/01/2023

# 620236

CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 29, WITH POLYGLUCOSAN BODIES; CMH29


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
3q27.1 Cardiomyopathy, familial hypertrophic, 29, with polyglucosan bodies 620236 Autosomal recessive 3 KLHL24 611295

TEXT

A number sign (#) is used with this entry because of evidence that hypertrophic cardiomyopathy-29 (CMH29) is caused by homozygous mutation in the KLHL24 gene (611295) on chromosome 3q27.


Description

Hypertrophic cardiomyopathy-29 (CMH29) is characterized by recurrent syncope, dyspnea on exertion, and palpitations. The clinical phenotype is associated with a poor prognosis due to lethal arrhythmias and cardiac failure. Cardiac muscle biopsies show intermyofibrillar accumulation of glycogen and polyglucosan bodies within cardiomyocytes, and skeletal muscle accumulation of glycogen has also been observed (Hedberg-Oldfors et al., 2019).

For a general phenotypic description and discussion of genetic heterogeneity of hypertrophic cardiomyopathy, see CMH1 (192600).


Clinical Features

Hedberg-Oldfors et al. (2019) reported 2 unrelated consanguineous families, of Iraqi (family A) and Iranian (family B) origin, segregating autosomal recessive hypertrophic cardiomyopathy (CMH) and mutation in the KLHL24 gene. Of 11 affected young adults in the 2 families, 3 died suddenly and 1 underwent cardiac transplantation due to heart failure. Onset of symptoms was in the second or third decade of life, and the initial symptoms included palpitations, syncope, shortness of breath, and dyspnea on exertion. Echocardiographic findings were reported for 8 patients and showed increased septal and posterior wall thickness, with asymmetric septal hypertrophy in 3 patients. Most had a small left ventricular cavity with reduced left ventricular end-diastolic volumes, and left ventricular outflow obstruction was documented in 3 patients. Cardiac biopsies from an affected sister and brother in family A showed cardiomyocyte hypertrophy, accumulation of glycogen, and scattered cardiomyocytes with polyglucosan bodies. Electron microscopy showed intermyofibrillar accumulation of glycogen, tubular structures, and irregularly arranged intermediate filaments. Skeletal muscle biopsies from patients in both families showed focal subsarcolemmal and intermyofibrillar accumulation of glycogen, as well as intermediate filaments with desmin (DES; 125660) immunostaining, together causing a jagged appearance at the edges of both type 1 and type 2 muscle fibers that the authors designated as 'cogwheel-like.' No signs of muscular atrophy or weakness were found in the patients, and nerve conduction studies were normal. No skin abnormalities were found.


Inheritance

The transmission pattern of CMH29 in the families reported by Hedberg-Oldfors et al. (2019) was consistent with autosomal recessive inheritance.


Mapping

In a large multigenerational Iranian family (family B) segregating autosomal recessive CMH, Hedberg-Oldfors et al. (2019) performed linkage analysis and identified an approximately 3.4-Mb region of homozygosity on chromosome 3 with an estimated lod score of 3.6. The interval was defined by rs9877496 and rs73175592.


Molecular Genetics

By exome sequencing in 2 unrelated families segregating autosomal recessive hypertrophic cardiomyopathy, Hedberg-Oldfors et al. (2019) identified homozygosity for mutations in the KLHL24 gene: in family A, of Iraqi origin, an affected brother and sister were homozygous for a nonsense mutation (E350X; 611295.0005); and in family B, of Iranian origin, 4 sibs and an affected cousin with CMH mapping to chromosome 3 were homozygous for a missense mutation (R306H; 611295.0006). The unaffected parents in both pedigrees were heterozygous for the respective mutations, neither of which was found in the Greater Middle Eastern Variome database. Western blot analysis of cardiac tissue from the sibs in family A showed marked upregulation of desmin.


Animal Model

Hedberg-Oldfors et al. (2019) knocked down the cardiac-specific zebrafish homolog of KLHL24, klhl24a, and observed defects in heart function at 48 hours postfertilization (hpf). The defects initially manifested as pericardial edema, alterations in heart rate, and reduced blood circulation; ventricular failure and blocked blood circulation were observed at 72 hpf. Site-specific mutagenesis corresponding to the human mutations E350X and R306H (see MOLECULAR GENETICS) gave rise to heart defects in more than 70% of embryos, and the mutant mRNA could not rescue the knockdown of endogenous klhl24a.


REFERENCES

  1. Hedberg-Oldfors, C., Abramsson, A., Osborn, D. P. S., Danielsson, O., Fazlinezhad, A., Nilipour, Y., Hubbert, L., Nennesmo, I., Visuttijai, K., Bharj, J., Petropoulou, E., Shoreim, A., and 12 others. Cardiomyopathy with lethal arrhythmias associated with inactivation of KLHL24. Hum. Molec. Genet. 28: 1919-1929, 2019. [PubMed: 30715372] [Full Text: https://doi.org/10.1093/hmg/ddz032]


Creation Date:
Marla J. F. O'Neill : 02/01/2023

Edit History:
alopez : 02/01/2023